Kamińska Daria, Skrzycki Michał
Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.
Chair and Department of Biochemistry, Medical University of Warsaw, Warszawa, Poland.
Cell Biol Int. 2024 Mar;48(3):253-279. doi: 10.1002/cbin.12114. Epub 2024 Jan 4.
Ischemia-reperfusion injury is an event concerning any organ under a procedure of transplantation. The early result of ischemia is hypoxia, which causes malfunction of mitochondria and decrease in cellular ATP. This leads to disruption of cellular metabolism. Reperfusion also results in cell damage due to reoxygenation and increased production of reactive oxygen species, and later by induced inflammation. In damaged and hypoxic cells, the endoplasmic reticulum (ER) stress pathway is activated by increased amount of damaged or misfolded proteins, accumulation of free fatty acids and other lipids due to inability of their oxidation (lipotoxicity). ER stress is an adaptive response and a survival pathway, however, its prolonged activity eventually lead to induction of apoptosis. Sustaining cell functionality in stress conditions is a great challenge for transplant surgeons as it is crucial for maintaining a desired level of graft vitality. Pathways counteracting negative consequences of ischemia-reperfusion are autophagy and lipid droplets (LD) metabolism. Autophagy remove damaged organelles and molecules driving them to lysosomes, digested simpler compounds are energy source for the cell. Mitophagy and ER-phagy results in improvement of cell energetic balance and alleviation of ER stress. This is important in sustaining metabolic homeostasis and thus cell survival. LD metabolism is connected with autophagy as LD are degraded by lipophagy, a source of free fatty acids and glycerol-thus autophagy and LD can readily remove lipotoxic compounds in the cell. In conclusion, monitoring and pharmaceutic regulation of those pathways during transplantation procedure might result in increased/improved vitality of transplanted organ.
缺血再灌注损伤是移植过程中涉及任何器官的一种情况。缺血的早期结果是缺氧,这会导致线粒体功能障碍和细胞ATP减少。这会导致细胞代谢紊乱。再灌注还会因复氧和活性氧生成增加以及随后引发的炎症而导致细胞损伤。在受损和缺氧的细胞中,内质网(ER)应激途径会因受损或错误折叠蛋白质数量增加、由于氧化能力不足导致的游离脂肪酸和其他脂质积累(脂毒性)而被激活。内质网应激是一种适应性反应和生存途径,然而,其长期激活最终会导致细胞凋亡的诱导。在应激条件下维持细胞功能对移植外科医生来说是一项巨大挑战,因为这对于维持所需的移植物活力水平至关重要。对抗缺血再灌注负面后果的途径是自噬和脂滴(LD)代谢。自噬清除受损的细胞器和分子,将它们输送到溶酶体,消化后的更简单化合物是细胞的能量来源。线粒体自噬和内质网自噬可改善细胞能量平衡并减轻内质网应激。这对于维持代谢稳态从而维持细胞存活很重要。脂滴代谢与自噬相关,因为脂滴可通过脂噬降解,脂噬是游离脂肪酸和甘油的来源,因此自噬和脂滴可以很容易地清除细胞中的脂毒性化合物。总之,在移植过程中监测和药物调节这些途径可能会提高/改善移植器官的活力。